II期乳腺癌的辅助化疗：NSABP临床试验简要概述 - Suppr

Suppr

超能文献

Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.

作者信息

Wolmark N, Fisher B

出版信息

World J Surg. 1985 Oct;9(5):699-706. doi: 10.1007/BF01655183.

DOI:10.1007/BF01655183

PMID:2856855

Abstract

摘要

相似文献

Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.II期乳腺癌的辅助化疗：NSABP临床试验简要概述

World J Surg. 1985 Oct;9(5):699-706. doi: 10.1007/BF01655183.

Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.乳腺癌辅助治疗：NSABP经验简述及对新辅助化疗的一些思考

Recent Results Cancer Res. 1986;103:54-68. doi: 10.1007/978-3-642-82671-9_6.

Adjuvant tamoxifen and chemotherapy in stage II breast cancer: interim findings from NSABP protocol B-09.II期乳腺癌的辅助性他莫昔芬与化疗：NSABP B-09方案的中期研究结果

World J Surg. 1985 Oct;9(5):750-5. doi: 10.1007/BF01655190.

The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.

Recent Results Cancer Res. 1984;96:148-54. doi: 10.1007/978-3-642-82357-2_18.

A brief overview of findings from NSABP trials of adjuvant therapy.美国国立外科辅助乳腺和肠道项目（NSABP）辅助治疗试验结果的简要概述。

Recent Results Cancer Res. 1984;96:55-65. doi: 10.1007/978-3-642-82357-2_8.

Adjuvant therapy in primary breast cancer.原发性乳腺癌的辅助治疗。

Surg Clin North Am. 1985 Feb;65(1):161-80. doi: 10.1016/s0039-6109(16)43540-1.

A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.

Recent Results Cancer Res. 1984;96:74-89. doi: 10.1007/978-3-642-82357-2_10.

Eight-year follow-up of adjuvant therapy for stage II breast cancer.

World J Surg. 1985 Oct;9(5):738-49. doi: 10.1007/BF01655189.

Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.

J Clin Oncol. 1989 May;7(5):572-82. doi: 10.1200/JCO.1989.7.5.572.

Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).亚利桑那大学辅助性乳腺癌试验（1974 - 1984年）的当前结果。

Recent Results Cancer Res. 1984;96:133-40. doi: 10.1007/978-3-642-82357-2_16.

引用本文的文献

Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group.绝经后可切除的淋巴结阳性乳腺癌患者。他莫昔芬与FEC 50（6个周期）、FEC 50（6个周期）加他莫昔芬与对照组——一项四臂随机试验的初步结果。法国辅助治疗研究组。

Drugs. 1993;45 Suppl 2:60-7. doi: 10.2165/00003495-199300452-00010.

本文引用的文献

Dose-response effect of adjuvant chemotherapy in breast cancer.辅助化疗在乳腺癌中的剂量反应效应。

N Engl J Med. 1981 Jan 1;304(1):10-5. doi: 10.1056/NEJM198101013040103.

The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.近期NSABP原发性乳腺癌治疗临床试验对肿瘤生物学理解的贡献——研究结果概述

Cancer. 1980 Aug 15;46(4 Suppl):1009-25. doi: 10.1002/1097-0142(19800815)46:4+<1009::aid-cncr2820461326>3.0.co;2-h.

Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma.

J Mt Sinai Hosp N Y. 1966 Jan-Feb;33(1):1-27.

Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.乳腺癌的手术辅助化疗：十年合作研究的结果

Ann Surg. 1968 Sep;168(3):337-56. doi: 10.1097/00000658-196809000-00004.

L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.左旋苯丙氨酸氮芥（L-PAM）用于原发性乳腺癌的治疗。早期研究结果报告。

N Engl J Med. 1975 Jan 16;292(3):117-22. doi: 10.1056/NEJM197501162920301.

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).

Cancer. 1977 Jun;39(6 Suppl):2883-903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验